Related Experiment Video

Updated: Apr 20, 2026

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE
07:10

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE

Published on: April 21, 2019

17.1K

Is skin testing reliable for confirming sensitization to seminal fluid proteins?

Yuval Tal1, Jonathan A Bernstein2, Miriam Lorberbaum1

  • 1Allergy and Clinical Immunology Unit, Internal Medicine Department, Hadassah - Hebrew University Medical Center, Jerusalem, Israel.

The Journal of Allergy and Clinical Immunology. in Practice
|December 3, 2014
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

An In Vitro Skin Irritation Test SIT using the EpiDerm Reconstructed Human Epidermal RHE Model
21:16

An In Vitro Skin Irritation Test SIT using the EpiDerm Reconstructed Human Epidermal RHE Model

Published on: July 13, 2009

69.5K
A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo
11:17

A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo

Published on: August 11, 2018

12.7K

Related Experiment Videos

Last Updated: Apr 20, 2026

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE
07:10

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE

Published on: April 21, 2019

17.1K
An In Vitro Skin Irritation Test SIT using the EpiDerm Reconstructed Human Epidermal RHE Model
21:16

An In Vitro Skin Irritation Test SIT using the EpiDerm Reconstructed Human Epidermal RHE Model

Published on: July 13, 2009

69.5K
A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo
11:17

A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo

Published on: August 11, 2018

12.7K

Related Concept Videos

Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

184
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
184

Articles linked to this work by shared authors, journal, and citation graph.

Conditioning chemotherapy exposure is associated with epigenetic modifications in Clostridioides difficile isolates from stem cell transplant recipients.

Research square·2026

Sex Hormones Regulate T-Cell Responses Associated With Rheumatoid Arthritis.

Cell biology international·2026

Clinical response and corresponding blood transcriptome pathways before and after treatment of hereditary angioedema prodromes compared to active swelling attacks.

The Journal of allergy and clinical immunology·2024

Clinical severity classes in COVID-19 pneumonia have distinct immunological profiles, facilitating risk stratification by machine learning.

Frontiers in immunology·2023

Atopic dermatitis and ocular allergy: common mechanisms and uncommon questions.

Current opinion in allergy and clinical immunology·2023

An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema: a two-part, randomised, double-blind, placebo-controlled, crossover phase 2 trial.

Lancet (London, England)·2023

Long-Acting Muscarinic Antagonist as an Alternative to Inhaled Corticosteroids in Type 2-Low Mild Asthma: A Randomized Crossover Non-inferiority Trial.

The journal of allergy and clinical immunology. In practice·2026

Heart rate variability patterns differentiate between positive and negative oral food challenges in children with food allergy.

The journal of allergy and clinical immunology. In practice·2026

Persistent uncontrolled severe asthma despite widespread biologic use: care gaps from the French FASE2-CPHG real-world study.

The journal of allergy and clinical immunology. In practice·2026

Asthmatics with increased triglyceride-glucose index are at elevated risk of exacerbations independent of type 2 inflammation: A prospective cohort study.

The journal of allergy and clinical immunology. In practice·2026

Lessons Learned From Fatal and Near-Fatal Perioperative IgE-Mediated Anaphylaxis.

The journal of allergy and clinical immunology. In practice·2026

Linking Quality Measures to Guideline Recommendations in Allergy-Immunology: Challenges and Opportunities: A Workgroup Report of the AAAAI Measures Stewardship Committee.

The journal of allergy and clinical immunology. In practice·2026

Research on Epidemiology of Metal Sensitization in Japan.

Dermatitis : contact, atopic, occupational, drug·2026

A Follicle-Targeting Dual Anti-Fungal and Immunomodulatory Platform Against Fungal Invasion and Relapse Prevention.

Small (Weinheim an der Bergstrasse, Germany)·2026

Evaluation of galactomannan assay in diagnosing invasive aspergillosis.

Iranian journal of microbiology·2026

Case Report: Anti-GQ1b antibody-positive overlap syndrome: a pediatric case involving the brainstem, spinal cord, and peripheral nerves.

Frontiers in immunology·2026

The evaluation of cytokine profiles in atopic dermatitis patients treated with dupilumab: association with ocular complications.

Frontiers in immunology·2026

Patient Perspectives on Dupilumab Therapy for Atopic Dermatitis: Experiences, Expectations and Treatment Impact.

The Australasian journal of dermatology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us